Rallis India Ltd Q3 FY26 – ₹623 Cr Revenue (+19% YoY), PAT Collapses to ₹2 Cr, EPS ₹0.10: Tata Legacy Meets Farm-Sector Mood Swings
1. At a Glance – Blink and You’ll Miss the Profit
Rallis India is that one Tata Group relative who wears a crisp suit, has a 150-year family history, but still manages to trip over quarterly profits like it’s banana peel season. Q3 FY26 delivered ₹623 crore revenue, up a handsome 19% YoY, which on the surface looks like a bumper crop. But dig one inch deeper and you’ll find PAT of just ₹2 crore, down from ₹11 crore last year and ₹102 crore in the previous quarter. Yes, the same company. Same Tata logo. Same factories.
At a market cap of ₹4,478 crore, the stock trades around ₹230, down ~20% in 3 months and ~37% in 6 months, meaning investors have already harvested their losses. P/E sits at 24.4x, ROCE at 10.1%, ROE a sleepy 6.65%, and debt is almost non-existent at ₹61 crore (D/E 0.03). Dividend yield? A polite 1.09%, like a thank-you card after disappointing guests.
So the headline question: is this just one bad monsoon quarter, or is Rallis slowly becoming a case study in “Great brand, average returns”? Let’s put on our detective hat and walk into the farm.
Rallis India is not a fly-by-night pesticide trader. This is a Tata Group company with operations stretching across crop protection, seeds, and organic inputs, touching 80% of India’s districts and over 8 million farmers. That’s not a business, that’s a rural network masquerading as a company.
And yet, despite this reach, Rallis has mastered the art of inconsistent profitability. One quarter it flexes margins, the next quarter it apologises with “industry headwinds” and “weather disruptions.” Over the last few years, sales growth has crawled at ~3% CAGR, profit growth has actually gone negative, and ROE has steadily slipped from double digits to mid-single digits.
Q3 FY26 is a perfect example. Revenues surged, operating profit stood at ₹58 crore, but other income went negative (-₹26 crore) and margins compressed, dragging PAT to almost zero. This is not fraud. This is not accounting gymnastics. This is plain old agrochemical cyclicality mixed with cost pressure and poor operating leverage.
So before you scream “Tata premium!”, remember: pedigree does not fertilise margins. Execution does.
3. Business Model – WTF Do They Even Do?
Imagine Rallis as a full-stack farmer buddy.
Seeds for sowing
Insecticides for pests
Herbicides for weeds
Fungicides for diseases
Organic nutrients for ESG presentations
Roughly 82% of revenue comes from Crop Care, 16% from Seeds, and the rest from non-agro products. Within crop care, domestic branded formulations dominate, with insecticides leading the pack, followed by fungicides and herbicides.
Exports contribute ~20% of revenue, spanning 41 countries, while contract manufacturing for global agro giants adds a steady but low-glamour income stream. The company runs five manufacturing plants across Maharashtra and Gujarat, producing both technicals and formulations.
Rallis also owns Metahelix Life Sciences (seeds) and Zero Waste Agro Organics, both merged into the parent to create a “seed-to-soil” narrative. The innovation engine is the Rallis Innovation Chemistry Hub (RICH), which sounds like a Marvel villain hideout but is actually their R&D backbone.
The business itself is solid. The problem? Agrochemicals are brutally cyclical, price-sensitive, weather-dependent, and politically allergic. Execution has to be near-perfect. Rallis, unfortunately, is more “average student with famous surname.”
4. Financials Overview – Numbers Don’t Lie, They Just Roast You
Result Type Lock: The latest announcement clearly states “Third Quarter and Nine Months Ended December 31, 2025” → Quarterly Results locked.
